Search
for
Sort by
Research 31–60 of 1000+
- Cutaneous lupus erythematosus
- Cutaneous reactions to recombinant cytokine therapy
- Adverse Cutaneous Reactions to Antipsychotics
- Adverse Cutaneous Reactions to Mood Stabilizers
- Adverse Cutaneous Reactions to Antidepressants
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Mucocutaneous reactions to chemotherapy
- Adverse Drug Reactions in HIV/AIDS Patients on Highly Active Antiretro Viral Therapy: A Review of Prevalence
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Anticonvulsant-Induced Cutaneous Reactions
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Cutaneous Lupus Erythematosus
- Cutaneous Drug Reaction Case Reports
- Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Hair and Scalp Changes in Cutaneous and Systemic Lupus Erythematosus
- Hypersensitivity Reactions to Homemade Topical Preparations.
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- Scalp Bogginess in the Presence of Lichen Planopilaris: Isolated Occurrence or Reactionary Process?
- Dermatoses of pregnancy
- Cirmcumscribed juvenile pityriasis rubra pilaris in a 5-year-old-girl treated with topical keratolytic and steroid
- Skin Diseases in Pregnancy
- Acquired scalp alopecia. Part I: A review
- Lupus panniculitis clinically simulating alopecia areata
- Ashy Dermatosis
- Urticaria induced by laser epilation: A clinical and histopathological study with extended follow‐up in 36 patients
- Self-Assessment
- Hypersensitivity Diseases
- Cutaneous complications of chemotherapeutic agents
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons